Għaddejjin (updated on 01/12/2023)
Referenza:
NAT/880-EESC-2023Rapporteur:
Sessjoni plenarja:
583 -
Dec 13, 2023 Dec 14, 2023
Opinjonijiet fejn membri tal-Grupp ta’ Min Iħaddem huma relatur/korelatur/relatur ġenerali
Pages
Displaying 1 - 10 of 812
Għaddejjin (updated on 30/11/2023)
Referenza:
NAT/915-EESC-2023Rapporteur:
Co-rapporteur:
Sessjoni plenarja:
583 -
Dec 13, 2023 Dec 14, 2023
Għaddejjin (updated on 29/11/2023)
Referenza:
ECO/633-EESCReferral:
COM(2023) 903 final Rapporteur:
Sessjoni plenarja:
584 -
Jan 17, 2024 Jan 18, 2024
Għaddejjin (updated on 29/11/2023)
Referenza:
INT/1042-EESC-2023Rapporteur:
Sessjoni plenarja:
583 -
Dec 13, 2023 Dec 14, 2023
This initiative aims at providing detailed rules to support the smooth functioning of the cooperation and consistency mechanism established by the General Data Protection Regulation (GDPR).
Għaddejjin (updated on 28/11/2023)
Referenza:
NAT/894-EESCRapporteur:
Co-rapporteur:
Microplastics are persistent, very mobile, and hard to remove from nature. Microplastics are widespread in the world and in the human body, and a cause of growing concerns. Plastic pellets are found in water and soil, including agricultural lands, and harm ecosystems and biodiversity. Plastic pellets are the one of the largest sources of unintentional microplastic pollution.
For the first time, the European Commission proposes measures to prevent microplastic pollution from the unintentional release of plastic pellets.
Għaddejjin (updated on 24/11/2023)
Referenza:
SOC/786-EESCReferral:
COM(2023) 715 final COM(2023) 716 final 2023/0404 CODCOM(2023) 716 final 2023/0404 CODCOM(2023) 719 final 2023/0405 NLECOM(2023) 719 final 2023/0405 NLERapporteur:
Co-rapporteur:
Għaddejjin (updated on 24/11/2023)
Referenza:
ECO/624-EESC-2023Referral:
COM(2023) 262 final 2023/0158 CNSRapporteur:
Sessjoni plenarja:
583 -
Dec 13, 2023 Dec 14, 2023
Għaddejjin (updated on 22/11/2023)
Referenza:
CCMI/212-EESC-2023Rapporteur:
Lech PILAWSKI (Employers - GR I/Poland), Lech PILAWSKI (Employers - GR I/Poland) (Employers - GR I / Poland)
Co-rapporteur:
Thomas STUDENT (Germany)
Sessjoni plenarja:
583 -
Dec 13, 2023 Dec 14, 2023
The Covid 19-pandemic has drawn attention to the role of the pharmaceutical industry and to production, availability and affordability of medicines and medicinal products on the European market.
Dependency on critical ingredients, such as active pharmaceutical ingredients (APIs), became obvious when China and India limited exports. According to current data, up to 80% of APIs used in Europe and about 40% of finished medicines sold in Europe come from China or India. The European Union's increasing dependence on API supplies has led to a partial loss of capability to manufacture active substances independently, which poses a potential threat to public health in the countries of the European Union.
Għaddejjin (updated on 22/11/2023)
Referenza:
INT/1048-EESCReferral:
COM(2023) 535 final Rapporteur:
Co-rapporteur:
SMEs face major uncertainties, supply constraints, labour shortages and unfair competition.
Għaddejjin (updated on 22/11/2023)
Referenza:
ECO/613-EESC-00860Rapporteur: